Federal Contractor Profile
Cellphire, INC.
$126M obligated·6 awards·2 agencies·4 NAICS
Federal Contracts
Showing contracts 1–27 of 27 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Mar 31, 2025 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $6.8M |
| Nov 27, 2024 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $9.1M |
| Mar 8, 2024 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $22M |
| Oct 11, 2023 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $1.1M |
| Aug 7, 2023 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH20C0067 | 541714 | CLINICAL TRIAL IN SUPPORT OF TRAUMA INDICATIONS FOR LYOPHILIZED CANINE BLOOD PRODUCTS | $759K |
| Apr 26, 2023 | Department of DefenseARMY MED RES ACQ ACTIVITY | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $4.8M |
| Dec 22, 2022 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $208K |
| Aug 2, 2022 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $657K |
| Aug 2, 2022 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201300021C | 424210 | IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE | $3.5M |
| May 10, 2022 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $2.9M |
| Oct 8, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0067 | 541714 | CLINICAL TRIAL IN SUPPORT OF TRAUMA INDICATIONS FOR LYOPHILIZED CANINE BLOOD PRODUCTS | $252K |
| Apr 2, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $3.8M |
| Jan 26, 2021 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $1.1M |
| Sep 29, 2020 | Department of DefenseW6QK ACC-APG DURHAM | W911NF20C0051 | 541715 | LYOPHILIZED CANINE PLASMA SEQUENTIAL PHASE II | $1.1M |
| Jun 17, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $2.8M |
| May 28, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0067 | 541714 | CLINICAL TRIAL IN SUPPORT OF TRAUMA INDICATIONS FOR LYOPHILIZED CANINE BLOOD PRODUCTS | $241K |
| May 1, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0067 | 541714 | CLINICAL TRIAL IN SUPPORT OF TRAUMA INDICATIONS FOR LYOPHILIZED CANINE BLOOD PRODUCTS | $1.5M |
| Apr 13, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201300021C | 424210 | IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE | $33M |
| Feb 28, 2020 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $2.1M |
| Feb 18, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201300021C | 424210 | IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE | $1.3M |
| Dec 19, 2019 | Department of DefenseW4PZ USA MED RSCH ACQUIS ACT | W81XWH20C0030 | 541715 | CRYOPRESERVED PLATELET (CPP) DEVELOPMENT FOR US FDA LICENSURE | $2.6M |
| Jul 16, 2019 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201300021C | 424210 | IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE | $2.8M |
| Sep 27, 2018 | Department of DefenseW6QK ACC-APG DURHAM | W911NF18C0087 | 541715 | FREEZE DRIED PLASMA FOR CANINES | $999K |
| Jan 10, 2017 | Department of DefenseHQUSSOCOM | H9222217P0008 | 541712 | IGF::OT::IGF FEASIBILITY STUDY, SBIR PHASE I, TOPIC SOCOM163-007, FREEZE DRIED PLASMA FOR CANINES | $150K |
| Dec 15, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201300021C | 424210 | IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE | $25M |
| Sep 8, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201300021C | 424210 | IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE | $740K |
| May 19, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201300021C | 424210 | IGF::OT::IGF FOR OTHER FUNCTIONSCELLPHIRE | $2.2M |
Get Alerted Before Cellphire, INC.'s Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free